Tue, August 2, 2016
Mon, August 1, 2016
Fri, July 29, 2016
Thu, July 28, 2016
Wed, July 27, 2016
Tue, July 26, 2016
Mon, July 25, 2016
Fri, July 22, 2016
Thu, July 21, 2016
Wed, July 20, 2016
Tue, July 19, 2016
Mon, July 18, 2016
Fri, July 15, 2016
Thu, July 14, 2016
Wed, July 13, 2016
Tue, July 12, 2016
Mon, July 11, 2016
Fri, July 8, 2016
Thu, July 7, 2016
Wed, July 6, 2016
Tue, July 5, 2016
Fri, July 1, 2016
Thu, June 30, 2016
Wed, June 29, 2016

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $385 on, Jul 21st, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-385-on-jul-21st-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $383 to $385 on, Jul 21st, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016